It is not FDA-approved
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness or quality before they reach patients.
Peptide programs
A peptide program at Nuvira is a structured 12–16 weeks, reviewed by your treating clinician. A peptide is prescribed only when the clinician judges it appropriate for you, and it is filled through a licensed compounding pharmacy.
Elective. Compounded medications are not FDA-approved. Candidacy is decided at consultation. Individual results vary.
What a program is
Here, a peptide program is not a product you order. It is 12–16 weeks with a clear start, check-ins along the way and a scheduled review around day 90.
It begins with a review by the treating clinician. Only then is anything prescribed, and only if it is appropriate for you. The answer can be that nothing is. When it is, you hear it plainly.
Plainly: a peptide program is elective. Compounded medications are not FDA-approved. Nothing is prescribed unless the treating clinician judges it appropriate for you, and candidacy is decided at consultation. Individual results vary, and no outcome is promised.
A word worth understanding
If a peptide is prescribed, it is filled as a compounded medication. Three things follow from that word, and you should know them before you agree to anything.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness or quality before they reach patients.
Under the federal rule that covers state-licensed compounding pharmacies, a compounded medication is prepared for an identified patient, based on a valid prescription. At Nuvira, a prescription follows the treating clinician's review, never the other way round.
Federal rules limit which ingredients a pharmacy may use in compounding, and the FDA's view of specific ingredients can change. It is one reason this site carries no list of compounds.
One more plain fact: a pharmacy's license is not an FDA approval of what it prepares. A peptide program is elective, and candidacy is decided at consultation.
How a program runs
The same order as everything at Nuvira, seen from the peptide side.
No pressure, and no health details through the website. You say what brings you here. We say whether a consultation makes sense.
The treating clinician reviews whether a peptide is appropriate for you, and the answer can be no. Whatever is proposed goes into a plain-language plan: options, risks, evidence and cost.
Anything prescribed is written for you and filled through a licensed compounding pharmacy. If your plan also includes a cellular & biologic therapy, which is also elective and not FDA-approved, both sit in the same written plan with the same point of contact.
Check-ins through the program, and one point of contact for questions. If something needs to change, the treating clinician decides. You are not left to adjust anything on your own.
Included in every program. We look at where things stand and decide together what, if anything, comes next. Continuing is never assumed.
Elective. Compounded medications are not FDA-approved. Candidacy is decided at consultation. Individual results vary, and no outcome is promised.
Utah law requires us to give you this notice
THIS NOTICE MUST BE PROVIDED TO YOU UNDER UTAH LAW. This health care practitioner performs one or more stem cell therapies that have not yet been approved by the United States Food and Drug Administration. You are encouraged to consult with your primary care provider before undergoing a stem cell therapy.
Utah Code 58-1-512 · What this notice means
What we don't do
Here, a peptide is a clinical decision, not a product on a shelf. These four lines follow from that.
Elective. Compounded medications are not FDA-approved. Candidacy is decided at consultation.
Questions
No. Compounded medications are not FDA-approved, and a peptide program is elective. You read that here and hear it again at consultation, where candidacy is decided.
That isn't something a website can answer for you. A peptide is prescribed only after the treating clinician's review, and only if it is appropriate for you. If one is proposed, your written plan sets out the option, the risks, the evidence and the cost.
No. Booking a call commits nobody to anything. The clinician's review decides, and the answer can be that no peptide is appropriate.
Pricing is individualized. It is discussed at consultation and given to you in writing before anything is scheduled.
The first step
One conversation. No pressure, no pitch. If we're not the right fit, we'll say so.
Elective wellness services. Not FDA-approved to treat any condition. Individual results vary.